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Abstract
Human influenza viruses predominantly bind α2,6 linked sialic acid (SA) while avian viruses bind
α2,3 SA-containing complex glycans. Virulence and tissue tropism of influenza viruses have been
ascribed to this binding preference. We generated 2009 pandemic H1N1 (pH1N1) viruses with
either predominant α2,3 or α2,6 SA binding and evaluated these viruses in mice and ferrets. The
α2,3 pH1N1 virus had similar virulence in mice and replicated to similar titers in the respiratory
tract of mice and ferrets as the α2,6 and WT pH1N1 viruses. Immunohistochemical analysis
determined that all viruses infected similar cell types in ferret lungs. There is increasing evidence
that receptor specificity of influenza viruses is more complex than the binary model of α2,6 and
α2,3 SA binding and our data suggest that influenza viruses use a wide range of SA moieties to
infect host cells.
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Introduction
Influenza A viruses pose a major public health burden and are responsible for thousands of
deaths each year. Infection by influenza viruses is mediated via binding of the viral surface
glycoprotein hemagglutinin (HA) to terminally attached α2,3 or α2,6-linked sialic acids
(SA) on cell surface glycoproteins. Avian influenza viruses predominantly bind to glycan
receptors terminating in α2,3-linked SA (henceforth referred to as α2,3 SA) while human-
adapted viruses predominantly bind to glycan receptors terminating in α2,6-linked SA
(henceforth referred to as α2,6 SA)1–4. Receptor-binding specificity is an important
determinant of host-range restriction and transmission of influenza viruses4–7. The
distribution of SA in the human respiratory tract and duck intestine are thought to dictate the
specificity of viruses infecting these two species. In humans, the epithelium of the upper
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respiratory tract (nasal mucosa and nasopharynx) primarily expresses α2,6 SA, while the
lower respiratory tract (lung) contains both α2,3 and α2,6 SA8,9. In contrast, avian species
primarily express α2,3 SA in the cells lining the gut10. Ferrets, a well-established animal
model for influenza, have an α2,3 and α2,6 SA distribution similar to humans, while mice
predominantly express α2,3 SA and little α2,6 SA9,11,12. These observations have
dominated the field and led to the paradigm that 1) α2,3 SA binding viruses are limited in
their ability to replicate in humans and ferrets, and when they do so, they lead to severe
lower respiratory tract infection and 2) that α2,3 SA binding viruses are more virulent and
replicate more efficiently in mice than α2,6 SA binding viruses.
However, many recent studies provide evidence that this paradigm is an over-simplification.
Many avian influenza viruses are able to bind both α2,6 and α2,3 SA13,14 and a change in
host range is likely influenced by association with complex, physiologically diverse glycans
found on airway epithelial cells15. Additional glycan analyses found the presence of both
α2,6 and α2,3 SA in the human and ferret respiratory tract and in different avian
species12,16–18. Additionally, many influenza viruses with a preference for α2,3 SA, such as
H5N1 viruses, have been recovered from nasal secretions of naturally infected humans and
experimentally infected ferrets19,20.
In this study we assessed the role of receptor-binding preference of the viral HA on
virulence and tissue tropism of the 2009 pandemic H1N1 (pH1N1) virus. The pH1N1 virus
is known to predominantly bind to α2,6 SA and replicate well in the upper and lower
respiratory tract of mice and ferrets21–25. We generated two mutant viruses by engineering
four mutations in the viral HA gene to alter receptor-binding preference. One virus
contained mutations designed to increase binding to α2,6 SA (α2,6 pH1N1) and the second
virus had mutations designed to switch binding preference from α2,6 to α2,3 SA (α2,3
pH1N1). We found that the receptor specificity of the pH1N1 virus did not influence
virulence in mice or viral replication in the respiratory tract of mice or ferrets. Additionally,
we found that the WT, α2,6, and α2,3 pH1N1 viruses replicated in similar cell types in the
lungs of ferrets.
MATERIALS AND METHODS
Ethics Statement
All animal experiments were done at the NIH, in compliance with the guidelines of the
NIAID/NIH Institutional Animal Care and Use Committee (ACUC)
Cells and Viruses
Madin-Darby canine kidney (MDCK) cells (obtained from ATCC) were maintained in
minimum essential media (MEM) with 10% fetal bovine serum (FBS) and L-glutamine
(Gibco). 293T cells (obtained from ATCC), were maintained in Dulbecco’s MEM with 10%
FBS.
The reverse genetics system for generating the 2009 pandemic H1N1 (pH1N1) virus (A/
California/07/2009) was previously described26. Mutations were engineered using the
Stratagene Site-Directed Mutagenesis kit per the manufacturer’s protocol.
Recombinant viruses generated from reverse genetics plasmids were rescued in MDCK/
293T cell co-culture and propagated for 2 passages in either specific pathogen free (SPF)
embryonated eggs, for the α2,3 pH1N1 virus, or MDCK cells for the α2,6 pH1N1 virus. The
α2,6 pH1N1 did not grow to high titers in eggs and was propagated in MDCK cells to
prevent egg adaptation. The identity of viruses generated by reverse genetics was confirmed
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by genomic sequencing. All experiments were performed using viruses passaged no more
than 3 times in cells or eggs.
Dose dependent glycan binding of wild-type (WT) and mutant pH1N1 viruses
The receptor specificity of the WT, α2,3 and α2,6 pH1N1 viruses were investigated using a
selected panel of glycans comprised of both α2,3 and α2,6 sialylated glycans as previously
described27. Briefly, the wells of streptavidin-coated high binding capacity 384-well plates
(Pierce) were incubated with 50 μl of 2.4 μM biotinylated glycans overnight at 4°C. The
glycans included were 3′SLN, 3′SLN-LN, 3′SLN-LN-LN, 6′SLN and 6′SLN-LN. LN
corresponds to lactosamine (Galβ1-4GlcNAc) and 3′SLN and 6′SLN respectively
correspond to Neu5Acα2–3 and Neu5Acα2–6 linked to LN. Glycans were obtained from
the Consortium of Functional Glycomics (www.functionalglycomics.org). The viruses
(quantified in HAU/50 μl) were diluted to 250 μl with 1X PBS + 1% BSA. 50 μl of the
diluted virus was added to each of the glycan–coated wells and incubated overnight at 4 °C.
This was followed by three washes with 1X PBST (1X PBS + 0.1% Tween-20) and three
washes with 1X PBS. The wells were blocked with 1X PBS + 1% BSA for 2 h at 4 °C
followed by incubation with primary antibody (ferret anti–CA07/09 antisera; 1:200 diluted
in 1X PBS + 1% BSA) for 5 h at 4 °C. This was followed by three washes with 1X PBST
and three washes with 1X PBS. Finally the wells were incubated with the secondary
antibody (goat anti–ferret HRP conjugated antibody from Rockland; 1:200 diluted in 1X
PBS + 1% BSA). The wells were washed with 1X PBST and 1X PBS as before. The binding
signals were determined based on the HRP activity using the Amplex Red Peroxidase Assay
(Invitrogen) according to the manufacturer’s instructions. Appropriate negative controls
included were uncoated wells (without any glycans) to which just the virus, the antisera and
the antibody were added and glycan-coated wells to which only the antisera and the
antibody were added.
Characterization of viruses in mice
Replication of the viruses in the upper and lower respiratory tract of 6–8 week old female
BALB/c mice was determined as described28. Briefly, each mouse received 105 median
tissue culture infectious dose (TCID50) of virus in 50 μL intranasally (IN). Groups of four
mice per virus were sacrificed on days 1, 3 and 7 post-infection. Nasal turbinates were
collected by placing a clamp around the nose at the angle of the jaw and inverting 180° to
expose the nasal cavity. Forceps were used to collect the exposed nasal bone and tissue. The
entire lung was collected to measure viral titers in the lower respiratory tract. Tissues were
homogenized and clarified supernatant was aliquoted and titered on MDCK cells. The 50%
tissue culture infectious dose (TCID50) per gram of tissue was calculated by the Reed and
Muench method29.
The median mouse lethal dose (MLD50) was determined by administration of serial 10-fold
dilutions of the virus and observing weight loss and survival. In accordance with NIAID
ACUC guidelines, mice were euthanized if they lost more than 25% of their initial body
weight.
Replication of viruses in ferrets
We evaluated the replication kinetics of the viruses in the respiratory tract of 8–10 week old
ferrets as previously described 25. All ferrets were screened prior to infection to ensure that
they were naïve to seasonal influenza A and B, and to the viruses used in this study. Each
ferret was inoculated IN with 106 TCID50 of virus in 500 μL. Tissues were harvested for
pathology and to assess viral titers. Virus titers from tissue samples were determined on days
1, 3 and 5 post-infection as previously described30 and expressed in TCID50/g of tissue.
Briefly, tissues were weighed and Leibovitz’s L-15 (L-15, Invitrogen) was added at 5%
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(nasal turbinates and trachea) or 10% (lung) weight per volume (W/V). The nasopharynx
was homogenized in 1 mL of L-15. Tissues were homogenized and clarified supernatant was
aliquoted and titered on MDCK cells. The 50% tissue culture infectious dose (TCID50) per
gram of tissue was calculated by the Reed and Muench method29.
Immunohistochemistry
Ferret tissues were stained for influenza-specific antigens using antibodies derived against
the whole influenza virus in goats. Paraffin-embedded microtome sections were incubated at
60°C for 30 min and then incubated in xylene and serial dilutions of ethanol ranging from
100%-0% in dH2O for 5 minutes (min) at room temperature, with a final step of 3% H2O2 in
methanol for 10 min. For antigen retrieval, the slides were incubated in sodium citrate buffer
maintained at 95°C in a water bath for 30 min. Tissue sections were blocked in PBS-Tween
with 1.5% rabbit serum and stained with 1:300 dilution of anti-influenza polyclonal antibody
from Abcam (ab20841) and a secondary rabbit anti-goat biotin conjugated antibody (Vector
Labs). Bound antibody was visualized using the Vectastain ABC system and DAB stain
(Vector Labs) as per manufacturer’s instructions. Slides were counterstained with
hematoxylin (Vector Labs) and washed in Scott’s Tap water substitute to enhance the blue
stain. Permount was used per manufacturer’s instructions to mount the slides. A trained
veterinary pathologist analyzed all slides
Statistics
All viral titer data from replication kinetic experiments are expressed as mean ± standard
error and were analyzed using a Student’s t test, two-way ANOVA, or Mann-Whitney U test
in the graphing software, Prism (GraphPad). p values less than 0.05 are significant.
Results
Generation and rescue of α2,3 and α2,6 SA specific pH1N1 viruses
Multiple amino acids residues make up the receptor binding site (RBS) and control receptor
specificity. Since, the HA gene segment of the pH1N1 virus evolved from the 1918 Spanish
influenza H1N1 HA31,32, for this study we based changes in the pH1N1 RBS on those
already characterized for the 1918 HA. Two amino acid changes (D187E and D222G) in the
HA RBS of the 1918 H1N1 (A/South Carolina/1/18 or SC18) HA protein, referred to as the
avianized or AV18 virus, were demonstrated to change receptor specificity from α2,6 to
α2,3 SA6,33,34. Based on a detailed understanding of molecular contacts made by SC18 and
AV18 respectively with α2,6 and α2,3 SA receptors, we designed mutations in pH1N1 to
mimic the RBS of SC18 and AV18 (Table 1). The engineered mutations in the RBS of HA
included residues 187, 216, 222 and 224 (H1 numbering), which make critical molecular
contacts with the sialylated glycan receptors as depicted in the ribbon diagram in Figure 1A
and B27,35,36. Residues 187 and 222, as stated above, determine receptor specificity of the
1918 HA, while residues 216 and 224 help stabilize the receptor-binding pocket and have
been shown to enhance SA binding27. Two viruses were rescued; a α2,6 pH1N1 virus that
mimics SC18 at positions 216 and 224 and a α2,3 pH1N1 virus that is similar to AV18
(Table 1). To construct the α2,6 pH1N1 virus the HA segment was mutated at two sites, the
Isoleucine (I) at 216 (codon ATA) to Alanine (A) (codon GCA) and Glutamic acid (E) at
224 (codon GAA) to A (Codon GCA) where the underlined nucleotide indicates the
engineered change. The α2,3 pH1N1 virus was created by combining the α2,6 pH1N1
changes with the following two mutations Aspartic acid (D) at 222 (GAC) to a Glycine (G)
(GGC) and D187 (GAC) to Glutamic acid (E) (GAG) (Table 1). The receptor specificity of
the engineered pH1N1 viruses was determined by a dose-dependent glycan binding assay of
the WT, α2,6, and α2,3 pH1N1 viruses (Figure 1C–E). The WT and α2,6 pH1N1 viruses
revealed a strong preference for both long (6′SLN-LN) and short (6′SLN) α2,6 SA (Figure
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1C and D). In contrast, the α2,3 pH1N1 virus showed predominant binding to α2,3 SA with
some minimal binding to α2,6 SA (Figure 1E). Previous studies using this type of glycan
assay have shown that H5N1 viruses also have a low-level of α2,6 SA binding, similar to
the α2,3 pH1N1 virus35.
A single change at residue 222 from D to G in pH1N1 has been observed in nature and was
thought to lead to more severe disease in infected patients37,38. Interestingly, a single
D222G substitution results in a virus with dual binding specificity that strongly associates
with both α2,6 SA and α2,3 SA binding39,40. However, alteration of both D222 and D187
residues in the context of the other mutations at positions 216 and 224 results in switching
the dominant binding preference of pH1N1 virus from α2,6 SA to α2,3 SA. Other
investigators have also changed the receptor specificity of the pH1N1 virus by introducing a
single change at position 22641, demonstrating that multiple amino acids in the RBS can
influence receptor specificity.
Characterization of WT, α2,3 and α2,6 pH1N1 viruses in mice
To assess whether receptor specificity of the pH1N1 virus alters the tissue tropism of the
viruses, we tested their ability to replicate in the upper and lower respiratory tract of mice
(Figure 2A and B). Replication of WT, α2,6, and α2,3 pH1N1 viruses was determined in the
nasal turbinates and lungs of 4 individual animals on days 1, 3 and 7 post-infection. Despite
the predominance of α2,3 SA in mice11, all three viruses replicated to high titer in both the
nasal turbinates and lungs of all infected animals. Replication of WT and mutant pH1N1
viruses reached a peak on day 3 post-infection, with declining titers on day 7 as previously
described for the WT pH1N1 virus42 (Figure 2A and B). No significant difference was
observed among the WT, α2,6, and α2,3 pH1N1 viruses. Thus, receptor specificity of the
pH1N1 virus does not affect viral replication in the upper or lower respiratory tract of mice.
Previous studies have suggested that virulence of influenza viruses in mice correlates with
receptor specificity43–45. We determined the MLD50 for all three viruses by infecting mice
(4 per group) with serial 10-fold dilutions of virus from a dose of 106 to 103TCID50/50uL
IN and following daily weights and survival. In accordance with our animal study protocol,
mice that lost >25% of their original body weight were euthanized (Figure 2C and D). The
MLD50 was similar for all three viruses; 105.5, 104.8 and 104.9 for WT pH1N1, α2,6 pH1N1
and α2,3 pH1N1, respectively (Figure 2E). These results demonstrate that a receptor
preference for α2,3 SA does not alter the virulence of the pH1N1 virus in mice.
Characterization of WT, α2,3 and α2,6 pH1N1 viruses in ferrets
Plant lectins, SNA-I and MALII that have been used extensively to characterize the
distribution of α2,6 and α2,3 SA respectively in tissue sections from humans, ferrets, and
mice5,8,10,11,16,35,46,47. Staining of ferret tracheal tissue have shown that airway epithelial
cells predominantly express α2,6 SA while the submucosal glands express both α2,3 and
α2,6 SA. Lectin staining of the large airways in the lung demonstrated that epithelial cells
and the submucosal glands preferentially express α2,6 SA, while goblet cells and the
alveolar interstitium express both α2,3 and α2,6 SA9,12.
Since ferrets have a differential distribution of SA in the respiratory tract; we evaluated viral
replication kinetics in the nasal turbinates, nasopharynx, trachea and lungs of ferrets infected
with WT pH1N1, α2,3 pH1N1, or α2,6 pH1N1 viruses (Figure 3). In the nasal turbinates,
nasopharynx and trachea, all three viruses replicated to high titers that remained within a 10-
fold range from day 1 to 5 post-infection (Figure 3A–C). Replication of the WT and mutant
pH1N1 viruses was measured in the lower respiratory tract of ferrets by determining the
viral titer from the right middle lobe of the ferret lung (Figure 3D). On day 1 post-infection,
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the α2,3 pH1N1 and WT pH1N1 viruses replicated to high titers while the titer of α2,6
pH1N1 virus was much lower. However, by day 3 post-infection, replication of the α2,6
pH1N1 virus reached equivalent levels with WT and α2,3 pH1N1 viruses. Additionally, the
peak titer for WT pH1N1 and α2,3 pH1N1 was on day 1 post-infection while it was day 5
post-infection for α2,6 pH1N1 infected ferrets (Figure 3D). The difference in replication
kinetics in the ferret respiratory tissues is not related to receptor specificity, since the WT
and α2,6 pH1N1 viruses have similar receptor specificities but differed in their kinetics.
Additionally, WT and α2,3 pH1N1 viruses have distinct receptor preferences but had similar
replication kinetics in the lungs of ferrets at all days tested. These data suggest that receptor
specificity of pH1N1 virus does not greatly affect the replication in the ferret respiratory
tract and replication kinetics can vary among virus strains.
We assessed the severity of disease, distribution and kinetics of pathological lesions in the
lungs of ferrets (8 animals/virus). Ferrets infected with α2,6 pH1N1 virus showed the most
severe pathological changes and while animals infected with WT pH1N1 had
histopathological scores that were slightly less severe, the general degree of inflammation
was similar between the two viruses. In contrast, ferrets that received the α2,3 pH1N1 virus
displayed milder disease scores over the course of infection. The cellular composition of
inflammatory lesions was similar among all three viruses and consisted predominantly of
neutrophils and alveolar macrophages (days 1 and 3) that progressed to a more even
admixture of neutrophils, lymphocytes and plasma cells by day 5 post-infection. The
distribution of lesions differed among the three virus groups, ferrets infected with the α2,3
pH1N1 virus predominantly had inflammation associated with the alveolar interstitium on
day 1 post-infection and the submucosal glands (SMG) by day 5 post-infection (Figure 4A
and B). In contrast, animals infected with either α2,6 or WT pH1N1 viruses showed airway-
centered disease with a moderate degree of bronchiolar epithelial hyperplasia (Figure 4C–F)
on day 5 post-infection that likely reflects repair of epithelial cell damage. Bronchiolar
hyperplasia was not observed in animals infected with α2,3 pH1N1 virus. Thus, infection
with the α2,6 SA pH1N1 virus leads to more severe histopathological changes in the lungs
than the α2,3 SA pH1N1 virus.
We attempted to identify the cell types infected by the WT and mutant pH1N1 viruses in
ferret lungs on days 1 and 5 post-infection. With all three viruses, immunohistochemistry
showed that goblet and ciliated cells were positive for viral antigens (Figure 5) and viral
antigen was also found in the submucosal glands and alveolar interstitium (Figure 5).
Submucosal glands and ciliated epithelial cells in the ferret lungs were previously thought to
express only α2,6 SA12, yet the α2,3 pH1N1 virus replicated in these cell types on days 1
and 5. Therefore, our data demonstrate that receptor-binding preference does not
significantly alter the tissue tropism of the pH1N1 virus in the ferret respiratory tract.
Discussion
The previously held paradigm suggests that receptor specificity, based on association with
α2,6 SA or α2,3 SA, determines replication and virulence of influenza viruses. It was
believed that α2,6 SA binding viruses replicate more efficiently in the upper respiratory tract
of ferrets while α2,3 SA binding viruses replicate more efficiently in mice and in the lower
respiratory tract of ferrets8–11. A preference for α2,3 SA was also thought to increase
virulence of influenza viruses for mice43–45,48. In this study we introduced four amino acid
changes into the RBS of the 2009 pH1N1 HA, thereby changing the SA receptor-binding
preference of the 2009 pH1N1 virus from α2,6 SA to α2,3 SA. Characterization of these
engineered pH1N1 viruses revealed two important results. First, there was no difference in
the virulence of the WT, α2,6, and α2,3 pH1N1 viruses in mice. Second, there was no
difference in replication of the three viruses in the upper or lower respiratory tract of ferrets
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and mice. This result is consistent with the previously published findings on the replication
of 1918 pandemic H1N1 viruses, SC18 and AV18, in the ferret respiratory tract6.
Viruses with α2,3 SA specificity are expected to be more virulent in mice because the
respiratory tract of mice bears α2,3 SA43,45,48. However, many properties likely affect
virulence of influenza viruses in mice, such as the magnitude of replication, systemic spread
of the virus, and affinity or specificity for host receptors. In our study, the α2,3 pH1N1 virus
was as virulent as WT and α2,6 pH1N1 viruses, suggesting that virulence of the pH1N1
virus in mice is determined by factors other than receptor specificity. Our data support the
hypothesis that viral replication may determine virulence in the mouse model, since the WT
and α2,6 pH1N1 viruses replicated similarly to the α2,3 pH1N1 virus in the upper and lower
respiratory tract of mice. Others have shown that some pH1N1 viruses that were more
virulent in mice were derived as antibody escape mutants43,45 and resulted in increased
receptor avidity43. Since the pH1N1 virus does not produce a systemic infection in mice,
viral replication and receptor avidity rather than binding specificity likely play a role in
determining the virulence of this virus.
The differential distribution of SA in the human and ferret respiratory tract is thought to
limit the replication of α2,3 SA dominant influenza viruses to the lower respiratory
tract 8,9,12,16,41. However, in this study the α2,3 pH1N1 virus, generated based on the RBS
of the 1918 pandemic SC18 and AV18 viruses6, replicated as well as WT pH1N1 virus in
the upper and lower respiratory tract of ferrets and all viruses replicated in the same cell
types in the lungs of ferrets. In contrast, another recent study characterizing pH1N1 viruses
that differed in receptor specificity found that an α2,3 SA binding pH1N1 virus (HA/226R)
did not replicate well in the lungs of ferrets41. Taken together, these results suggest that the
specific amino acid composition of the HA RBS, rather than α2,3 and α2,6 SA preference
alone, affects viral replication in the lungs of ferrets and that influenza viruses likely
associate with a wide range of SA species on cells in the respiratory tract. Recent advances
in glycan array studies have demonstrated the complexity of SA association of influenza
viruses13,17. One study analyzing human bronchus and lung tissues demonstrated a
multitude of SA including both α2,6 and α2,3 linked SA in variable chain lengths17
suggesting that multiple SA moieties are available for influenza viral entry. Therefore,
physiological glycan diversity is more nuanced than characterization of terminal α2,6 and
α2,3 SA linkages alone. This is also evident in the case of the recently emerged H7N9
influenza virus, where the binding of this viral HA to physiological receptors in the human
respiratory tract could not be explained by its binding to a limited set of glycans with α2,6
and α2,3 SA linkages on prototypic glycan arrays15. Further characterization of the SA
composition of ferret and mice respiratory tracts is needed to fully understand the replication
of influenza viruses in these animal models.
We demonstrate that the α2,3 SA binding pH1N1 virus has similar virulence in mice and
replication in mice and ferrets as the WT and α2,6 pH1N1 viruses. Previous studies have
shown that association with α2,6 SA is required for respiratory droplet transmission of
influenza viruses in ferrets5,6,41,49–51. Therefore, further characterization of the
transmissibility of the α2,6 and α2,3 pH1N1 viruses generated in this study would be of
interest.
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Highlights
• We generated 2009 pH1N1 viruses with predominant α2,3 or α2,6 sialic acid
binding.
• receptor specificity did not influence virulence in mice.
• receptor specificity did not influence virus titers in the respiratory tract of mice.
• receptor specificity did not influence virus titers in the ferret respiratory tract.
• α2,6 and α2,3 pH1N1 viruses replicated in similar cell types in the lungs of
ferrets.
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Figure 1. Generation of α2,6 and α 2,3 specific pH1N1 viruses
Ribbon diagrams of the pH1N1 HA receptor binding pocket highlight the critical amino
acids in the receptor binding site of pH1N1 HA that bind with LSTc (α2,6-linked lactoseries
tetrasaccharide c) (A) and with LSTa (α2,3-linked lactoseries tetrasaccharide a) (B). Amino
acids at residues 187, 222, and 224 (H1 numbering) that make critical molecular contacts
with the sialylated glycan receptor in the receptor-binding pocket of HA are shown. These
residues were mutated to alter the receptor binding specificity of the pH1N1 HA (see main
text for details). Receptor specificity of wild-type (WT) and mutant pH1N1 viruses was
determined by dose-dependent glycan binding of inactivated whole viruses WT pH1N1 (C),
α2,6 pH1N1 (D) and α2,3 pH1N1 (E). The glycans are indicated in the figure legend,
orange colors represent α2,6 SA and blue colors represent α2,3 SA. Binding is expressed as
percentage after normalization with the maximum binding signal
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Figure 2. Receptor specificity does not alter replication or virulence in mice
Viral titers in the nasal turbinates (A) and lung (B) were determined from mice infected with
WT (■), α2,6 pH1N1 ( ), and α2,3 pH1N1 ( ). Each point represents an individual
animal, bars represent the mean titers among those animals, and the error bars represent the
standard error between animals. Virulence of the WT and mutant pH1N1 viruses was
measured in mice by inoculating animals with varying doses of virus (103, 104, 105
TCID50/50 μL). Mice were weighed every day and animals were sacrificed if they lost
≥25% of their pre-study weight. All animals infected with 104 (C) and 105 (D) TCID50/50
μL lost weight, but only those in the 105 group were sacrificed as indicated by the ( )
symbol. The calculated median mouse lethal dose (MLD50) for each virus was based upon
the survival rate of mice in the 104 and 105 group (E).
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Figure 3. Receptor specificity does not alter replication in ferrets
Titers of the WT pH1N1 (■), α2,6 pH1N1 ( ), and α2,3 pH1N1 ( ) from the regions of
the ferret respiratory tract defined on the diagram with dashed circles, include the nasal
turbinates (A), nasopharynx (B), trachea (C) and lung (D). Each point represents data from
an individual animal. Mean and standard error are indicated.
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Figure 4. Histopathology of lung sections in ferrets during infection with WT and mutant pH1N1
viruses
Lung lesions of α2,3 pH1N1 infected ferrets were observed in the alveolar interstitium on
day 1 post-infection (A) and in the submucosal glands (SMG) on day 5 post-infection (B).
The star (★) indicates SMGs demonstrating significant inflammation. Ferrets infected with
WT or α2,6 pH1N1 viruses displayed intense peribronchiolar inflammation on day 3 post-
infection (C, E) and bronchiolar hyperplasia on day 5 post-infection (D, F). Note the marked
thickening of the epithelial cell lining and degenerate cell debris in the lumen. A trained
veterinary pathologist analyzed all slides. Scale bars represent 100 μm.
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Figure 5. Localization of viral antigen in the lower respiratory tract of ferrets
The animal with the highest viral titer in the lungs from each group sacrificed on days 1 and
5 post-infection was analyzed for the location of viral antigen. Lung sections were stained
with polyclonal anti-influenza A antibody and counterstained with hematoxylin.
Representative images were captured for the bronchus, submucosal glands, and alveoli of a
ferret infected with WT pH1N1 virus or the mutant viruses. The black arrow (▶) represents
ciliated cells stained with influenza antigen, asterisk (*) mark antigen positive goblet cells,
and green arrows ( ) mark antigen positive inflammatory cells in the alveoli. A trained
veterinary pathologist analyzed all slides. Scale bars represent 50 μm.
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